表纸
市场调查报告书

恒温核酸增幅技术(INAAT)的全球市场-用途(感染性疾病,血液检验,研究),产品(计量仪器,试剂),终端用户(医院,参考实验室及其他)别预测及分析

Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Application (Infectious Diseases, Blood Screening, Research), Products (Instruments, Reagents), End-User (Hospital, Reference Laboratories, Other) - Global Forecast to 2018

出版商 MarketsandMarkets 商品编码 253613
出版日期 内容资讯 英文 215 Pages
订单完成后即时交付
价格
Back to Top
恒温核酸增幅技术(INAAT)的全球市场-用途(感染性疾病,血液检验,研究),产品(计量仪器,试剂),终端用户(医院,参考实验室及其他)别预测及分析 Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Application (Infectious Diseases, Blood Screening, Research), Products (Instruments, Reagents), End-User (Hospital, Reference Laboratories, Other) - Global Forecast to 2018
出版日期: 2014年05月16日内容资讯: 英文 215 Pages
简介

恒温核酸增幅技术(INAAT)市场由于胜过传统热感聚合酵素链锁反应(PCR)的先进等温条件分子检验的需求,一般预测今后将以13.5%的年复合成长率扩大,到2018年达到16亿5100万美元的规模。

本报告以恒温核酸增幅技术的全球市场为焦点,依用途,产品,终端用户,地区别预测以今后到2108年前这段期间为对象的交易规模转变,再汇整市场发展的影响要素,技术开发,竞争环境,有力企业等调查分析资讯。

第1章 简介

  • 调查的目的
  • 报告的范围
  • 调查方法
  • 一次·由二级资讯来源得来的重要资料

第2章 摘要整理

第3章 技术环境分析

  • 技术概要
  • 比较恒温核酸增幅技术(INAAT)与传统方法 - 竞争优势
  • 技术价值链分析
  • 技术上的能力与成熟度
  • 检验结果:比较一般的核酸增幅检查与INAAT临床现场即时检测
  • 各种INAAT比较分析

第4章 技术投资的未来性

  • 投资环境评估
    • 投资者网路
  • 技术评估:利害关系者间的授权·取得的可能性
  • 透过机会策略评估(OSE)电网,针对技术投资的潜力应用领域分析
    • OSE - 评估参数

第5章 市场环境分析

  • 市场区隔
  • 分子诊断法(MDX)的市场组合比例
    • 推动要素 - 说明
    • 阻碍因素 - 说明
    • 课题 - 说明
  • 需求面分析

第6章 产品市场

  • 产品·技术的改革 - 用途

第7章 用途市场

  • INAAT及分子诊断法
  • 感染性疾病诊断
  • 血液检验
  • 实验室研究
  • 癌症研究
  • INAAT的全球市场 - 各用途:2013-2018年
    • 感染性疾病市场 - 各地区
    • 血液检验市场 - 各地区
    • 研究市场 - 各地区

第8章 最终用途市场

  • 恒温核酸增幅技术的全球市场 - 各终端用户:2013-2018年
  • 全球市场 - 各终端用户
    • 医院市场 - 各地区
    • 参考实验室市场 - 各地区
    • 其他终端用户市场 - 各地区
  • 医院用INAAT市场 - 各用途
  • 参考实验室INAAT市场 - 各用途
  • 其他针对终端用户的INAAT市场 - 各用途

第9章 地区分析

  • 技术引进·开发 - 重要发现
    • 恒温核酸增幅技术的全球市场 - 各地区:2013-2018年
  • 北美
  • 欧洲
  • 亚洲
  • 其他地区
  • 高科技引进地区

第10章 竞争环境

  • 联盟、合作,协定
  • 新产品开发
  • M&A

第11章 企业简介

  • Alere
  • Becton, Dickinson and Company (Bd)
  • Biohelix
  • Biomerieux
  • 荣研化学株式会社
  • Hologic Gen-Probe
  • Lucigen
  • Meridian Bioscience, Inc.
  • New England Biolabs
  • Novartis Diagnostics
  • Nugen
  • Qiagen
  • Ustar Biotechnologies (Hangzhou) Ltd.

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: BT 2491

The isothermal nucleic acid amplification technology (INAAT) market is poised to reach $1,651 million by 2018 at a CAGR of 13.5% during the forecast period. Though PCR technology dominates the nucleic acid amplification technology market currently, adoption of INAAT technology is expected to be significant in coming years as it offers better clinical results in detecting pathogens during point-of-care testing.

Amongst different products, reagent segment is expected to grow at a faster growth due to its increasing demand in reliable, specific and faster detection of chronic diseases and genetic disorders. On the other hand, infectious disease was found to be the highest revenue generating application segment of isothermal nucleic acid amplification technology (INAAT) market in 2013; it is also expected to grow at higher CAGR of 14.4% during the forecast period due to increasing prevalence of various infectious diseases such as HIV and hepatitis A & B and increasing adoption of INAAT in advanced detection of pathogens globally. Amongst different end-users, adoption of INAAT technologies in reference laboratories is expected to be significant due to increasing importance of advanced technologies in different complex molecular testing.

North America commanded the largest market share of about 44% in 2013; whereas, Asian INAAT market is expected to witness the highest CAGR. High prevalence rate of infectious diseases and significant adoption of novel technologies are the major driving factors in the Asian INAAT market. Leading players in the global INAAT market are also expected to address the unmet needs in emerging nations such as India, China, South Africa, Singapore, and Middle East among others.

The grey area, while estimating the market size, includes the overlapping nature of the applications. The application segment included infectious diseases, blood screening, genetics, oncology, research. It was difficult to evaluate the appropriate applications of INAAT; these were later clarified with the help of various experts that participated during the study. Technology market is not estimated as these are proprietary technologies of leading companies. However, qualitative information such as technology evolution, value chain analysis, comparative analysis of various proprietary technologies, and technology roadmap are incorporated in the research study.

The notable players in the global isothermal nucleic acid amplification technology market include Alere, Inc. (U.S.), Becton, Dickinson & Company (U.S.), BioHelix (U.S.), bioMerieux (France), Hologic Gene-Probe (U.S.), and QIAGEN (The Netherlands).

The extensive market study covers a detailed coverage of market momentum, an in-depth analysis of various influencing factors as well as a comprehensive snapshot of competitive landscape. Such all-inclusive research would help market players to identify growth potential of different sub-segments and formulate a suitable strategy to enter various related industries with the best portfolio.

Table of Contents

1. Introduction

  • 1.1. Objectives Of The Study
  • 1.2. Report Scope
  • 1.3. Research Methodology
  • 1.4. Key Data From Secondary & Primary Sources

2. Executive Summary

3. Technology Landscape Analysis

  • 3.1. Technology Overview
  • 3.2. INAAT Vs. Conventional Methods - Competitive Advantages
  • 3.3. Technology Value Chain Analysis
  • 3.4. Technology Capability and Maturity
  • 3.5. Test Results General Nat Vs. INAAT Poct
  • 3.6. Comparative Analysis Of INAAT Types

4. Technology Investment Potential

  • 4.1. Investment Climate Assessment
    • 4.1.1. Investor Network
      • 4.1.1.1. Investment Climate Assessment
      • 4.1.1.2. Philanthropic Bodies
      • 4.1.1.3. Private Investors & Venture Capital Firms
      • 4.1.1.4. Insights on Current and Future Technology Investment Trends
      • 4.1.1.5. Some Of The Funds and Investments on INAAT
  • 4.2. Evaluation Of Technologies Available For Licensing & Acquisition For Stakeholders
  • 4.3. Analysis Of Potential Application Areas For Technology Investment Using Ose Grid
    • 4.3.1. Ose - Parameters For Evaluation

5. Market Landscape Analysis

  • 5.1. Market Segmentation
  • 5.2. Market Share in Molecular Diagnostics (Mdx)
  • 5.3. Market Dynamics
    • 5.3.1. Drivers - Description
    • 5.3.2. Restraints - Description
    • 5.3.3. Challenges - Description
  • 5.4. Demand-Side Analysis

6. Product Market

  • 6.1. Product/Technology Innovations - Applications
    • 6.1.1. Product/Technology Innovations - Applications
      • 6.1.1.1. INAAT Instrument Market - By Geography
      • 6.1.1.2. INAAT Reagent Market - By Geography

7. Applications Market

  • 7.1. INAAT & Molecular Diagnostics
  • 7.2. Infectious Disease Diagnostics
  • 7.3. Blood Screening
  • 7.4. Laboratory Research
  • 7.5. Cancer Research
  • 7.6. Global INAAT Market - By Application (2013-2018)
    • 7.6.1. INAAT Infectious Diseases Market, By Geography
    • 7.6.2. INAAT Blood Screening Market - By Geography
    • 7.6.3. INAAT Research Market - By Geography

8. End-User Market

  • 8.1. Global Isothermal Nucleic Acid Amplification Technology Market - By End User (2013-2018)
  • 8.2. Global Market - By End User
    • 8.2.1. INAAT Hospitals Market - By Geography
    • 8.2.2. INAAT Reference Laboratories Market - By Geography
    • 8.2.3. INAAT Other End-Users Market - By Geography
  • 8.3. INAAT Market For Hospitals, By Application
  • 8.4. INAAT Market For Reference Laboratories, By Application
  • 8.5. INAAT Market For Other End Users, By Application

9. Geographic Analysis

  • 9.1. Technology Adoption & Development - Key Findings
    • 9.1.1. Global Isothermal Nucleic Acid Amplification Technology Market - By Geography (2013-2018)
  • 9.2. North America
    • 9.2.1. North America - INAAT Market, By Application
    • 9.2.2. North America - Market, By Product
    • 9.2.3. North America - Market, By End User
  • 9.3. Europe
    • 9.3.1. Europe - INAAT Market, By Application
    • 9.3.2. Europe - Market, By Product
    • 9.3.3. Europe - Market, By End User
  • 9.4. Asia
    • 9.4.1. Asia - INAAT Market, By Application
    • 9.4.2. Asia - Market, By Product
    • 9.4.3. Asia - Market, By End User
  • 9.5. Rest Of The World (ROW)
    • 9.5.1. ROW- INAAT Market, By Application
    • 9.5.2. ROW- Market, By Product
    • 9.5.3. ROW- Market, By End User
  • 9.6. Regions With High Technology Adoption

10. Competitive Landscape

  • 10.1. Partnerships, Collaborations & Agreements
  • 10.2. New Product Launches
  • 10.3. Mergers and Acquisitions

11. Company Profiles

  • 11.1. Alere
  • 11.2. Becton, Dickinson and Company (Bd)
  • 11.3. Biohelix
  • 11.4. Biomerieux
  • 11.5. Eiken Chemical Co., Ltd.
  • 11.6. Hologic Gen-Probe
  • 11.7. Lucigen
  • 11.8. Meridian Bioscience, Inc.
  • 11.9. New England Biolabs
  • 11.10. Novartis Diagnostics
  • 11.11. Nugen
  • 11.12. Qiagen
  • 11.13. Ustar Biotechnologies (Hangzhou) Ltd.

List Of Tables

  • Table 1: NIH Funding Details and Estimation For Infectious Diseases During The Fiscal Year (Fy) 2010-2015
  • Table 2: Gates Foundation Grants ($) (2010-2014)
  • Table 3: Global Isothermal Nucleic Acid Amplification Technology Market, By Product, 2011-2018 ($Million)
  • Table 4: INAAT Instruments Market, By Geography, 2011-2018 ($Million)
  • Table 5: INAAT Reagents Market, By Geography, 2011-2018 ($Million)
  • Table 6: Global Isothermal Nucleic Acid Amplification Technology Market, By Application, 2011-2018 ($Million)
  • Table 7: INAAT Infectious Diseases Market, By Geography, 2011-2018 ($Million)
  • Table 8: INAAT Blood Screening Market, By Geography, 2011-2018 ($Million)
  • Table 9: INAAT Research Market, By Geography, 2011-2018 ($Million)
  • Table 10: Global Isothermal Nucleic Acid Amplification Technology Market, By End User, 2011-2018 ($Million)
  • Table 11: INAAT Hospitals Market, By Geography, 2011-2018 ($Million)
  • Table 12: INAAT Reference Laboratories Market, By Geography, 2011-2018 ($Million)
  • Table 13: INAAT Other End-Users Market, By Geography, 2011-2018 ($Million)
  • Table 14: INAAT Hospital Market Revenue, By Application, 2011-2018 ($Million)
  • Table 15: INAAT Reference Laboratories Market Revenue, By Application, 2011-2018 ($Million)
  • Table 16: INAAT Other End Users Market Revenue, By Application, 2011-2018 ($Million)
  • Table 17: North America: Market, By Application, 2011-2018 ($Million)
  • Table 18: North America: Market, By Product, 2011-2018 ($Million)
  • Table 19: North America: Market, By End User, 2011-2018 ($Million)
  • Table 20: Europe: Market, By Application, 2011-2018 ($Million)
  • Table 21: Europe: Market, By Product, 2011-2018 ($Million)
  • Table 22: Europe: Market, By End User, 2011-2018 ($Million)
  • Table 23: Asia: Market, By Application, 2011-2018 ($Million)
  • Table 24: Asia: Market, By Product, 2011-2018 ($Million)
  • Table 25: Asia: Market, By End User, 2011-2018 ($Million)
  • Table 26: ROW: Market, By Application, 2011-2018 ($Million)
  • Table 27: ROW: Market, By Product, 2011-2018 ($Million)
  • Table 28: ROW: Market, By End User, 2011-2018 ($Million)
  • Table 29: Partnerships, Collaborations & Agreements, 2011-2014
  • Table 30: New Product Launches, 2011-2014
  • Table 31: Mergers & Acquisitions, 2011-2014

List Of Figures

  • Figure 1: Research Methodology
  • Figure 2: INAAT Vs. Molecular Diagnostics: Market Revenue Forecast, 2011-2018
  • Figure 3: Technology Evolution
  • Figure 4: INAAT Vs. Conventional Methods - Competitive Advantages
  • Figure 5: Technology Value Chain Analysis
  • Figure 6: INAAT Capability Towards Poct
  • Figure 7: Test Results General Nat Vs. INAAT Poct
  • Figure 8: Comparative Analysis Of INAAT Types
  • Figure 9: Technology Roadmap
  • Figure 10: Attractive Forces For Increased Market Value
  • Figure 11: Investor Network
  • Figure 12: NIH Funds Towards Infectious Diseases
  • Figure 13: Opportunity Strategic Evaluation Analysis
  • Figure 14: Market Segmentation
  • Figure 15: Market Share in Molecular Diagnostics (Mdx)
  • Figure 16: Market Dynamics
  • Figure 17: Drivers Impact - Timeline
  • Figure 18: Restraints Impact - Timeline
  • Figure 19: Current and Emerging Opportunities
  • Figure 20: Demand-Side Analysis
  • Figure 21: Market Share, By Product, 2013-2018
  • Figure 22: Global Market, By Product, 2013 & 2018 ($Million)
  • Figure 23: INAAT Instruments Market, By Geography, 2013 & 2018 ($Million)
  • Figure 24: Global INAAT Reagents Market, By Geography, 2013 & 2018 ($Million)
  • Figure 25: Isothermal Nucleic Acid Amplification Technology Applications Market
  • Figure 26: INAAT Products Currently Available For Infectious Diseases
  • Figure 27: Market Share, By Application, 2013-2018
  • Figure 28: Global Market, By Application, 2013 & 2018 ($Million)
  • Figure 29: INAAT Infectious Diseases Market, By Geography, 2013 & 2018 ($Million)
  • Figure 30: INAAT Blood Screening Market, By Geography, 2013 & 2018 ($Million)
  • Figure 31: INAAT Research Market, By Geography, 2013 & 2018 ($Million)
  • Figure 32: Market Share, By End User, 2013-2018
  • Figure 33: Global Market, By End-User, 2013 & 2018 ($Million)
  • Figure 34: INAAT Hospitals Market, By Geography, 2013 & 2018 ($Million)
  • Figure 35: INAAT Reference Laboratories Market, By Geography, 2013 & 2018 ($Million)
  • Figure 36: INAAT Other End-Users Market, By Geography, 2013 & 2018 ($Million)
  • Figure 37: INAAT Hospital Market Revenue, By Application, 2013 Vs. 2018, ($Million)
  • Figure 38: INAAT Reference Laboratories Market Revenue, By Application, 2013 Vs 2018 ($Million)
  • Figure 39: INAAT Others End Users Market Revenue, By Application, 2013 Vs. 2018 ($Million)
  • Figure 40: Market Share, By Geography, 2013-2018
  • Figure 41: North America: Market, By Application, 2013 Vs. 2018 ($Million)
  • Figure 42: North America: Market, By Product, 2013 Vs.2018 ($Million)
  • Figure 43: North America: Market, By End User, 2013 Vs. 2018 ($Million)
  • Figure 44: Europe: Market, By Application, 2013 Vs.2018 ($Million)
  • Figure 45: Europe: Market, By Product, 2013 Vs.2018 ($Million)
  • Figure 46: Europe: Market, By End User, 2013 Vs.2018 ($Million)
  • Figure 47: Asia: Market, By Application, 2013 Vs.2018 ($Million)
  • Figure 48: Asia: Market, By Product, 2013 Vs.2018 ($Million)
  • Figure 49: Asia: Market, By End User, 2013 Vs.2018 ($Million)
  • Figure 50: ROW: Market, By Application, 2013 Vs.2018 ($Million)
  • Figure 51: ROW: Market, By Product, 2013 Vs.2018 ($Million)
  • Figure 52: ROW: Market, By End User, 2013 Vs.2018 ($Million)
  • Figure 53: Key Growth Strategies Of The Global Isothermal Nucleic Acid Amplification Technologies Market, 2011-2014
Back to Top